Financial Contrast: RHÖN-KLINIKUM Aktiengesellschaft (OTCMKTS:RKAGY) and Henry Schein (NASDAQ:HSIC)

RHÖN-KLINIKUM Aktiengesellschaft (OTCMKTS:RKAGY) and Henry Schein (NASDAQ:HSIC) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations.

Profitability

This table compares RHÖN-KLINIKUM Aktiengesellschaft and Henry Schein’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
RHÖN-KLINIKUM Aktiengesellschaft	N/A	N/A	N/A
Henry Schein	2.96%	15.97%	5.56%

Institutional & Insider Ownership

0.2% of RHÖN-KLINIKUM Aktiengesellschaft shares are owned by institutional investors. Comparatively, 96.6% of Henry Schein shares are owned by institutional investors. 0.9% of Henry Schein shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Earnings & Valuation

This table compares RHÖN-KLINIKUM Aktiengesellschaft and Henry Schein”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RHÖN-KLINIKUM Aktiengesellschaft	N/A	N/A	N/A	$4.50	1.81
Henry Schein	$13.18 billion	0.75	$398.00 million	$3.43	26.03

Henry Schein has higher revenue and earnings than RHÖN-KLINIKUM Aktiengesellschaft. RHÖN-KLINIKUM Aktiengesellschaft is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for RHÖN-KLINIKUM Aktiengesellschaft and Henry Schein, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RHÖN-KLINIKUM Aktiengesellschaft	0	0	0	0	0.00
Henry Schein	1	6	8	0	2.47

Henry Schein has a consensus price target of $92.93, suggesting a potential upside of 4.08%. Given Henry Schein’s stronger consensus rating and higher probable upside, analysts clearly believe Henry Schein is more favorable than RHÖN-KLINIKUM Aktiengesellschaft.

Summary

Henry Schein beats RHÖN-KLINIKUM Aktiengesellschaft on 10 of the 11 factors compared between the two stocks.

About RHÖN-KLINIKUM Aktiengesellschaft

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. It also operates acute hospitals, medical care centers, and rehabilitation hospitals. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.

About Henry Schein

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.